ReP USP - Resultado da busca

Artigo de periodico
Exploring nanoparticular platform in delivery of repurposed drug for Alzheimer’s disease: current approaches and future perspectives (2024)
Chakraborty, Snigdha; Vishwas, Sukriti ; Harish, Vancha; Gupta, Gaurav ; Paudel, Keshav Raj ; Dhanasekaran, Muralikrishnan; Goh, Bey Hing ; Zacconi, Flavia; Pinto, Terezinha de Jesus Andreoli ; Kumbhar, Popat; Disouza, John; Dual, Kamal; Singh, Sachin Kumar
Source: Expert Opinion on Drug Delivery. Unidade: FCF
Subjects: DOENÇA DE ALZHEIMER, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAKRABORTY, Snigdha et al. Exploring nanoparticular platform in delivery of repurposed drug for Alzheimer’s disease: current approaches and future perspectives. Expert Opinion on Drug Delivery, v. 21, p. 1771-1792, 2024Tradução . . Disponível em: https://dx.doi.org/10.1080/17425247.2024.2414768. Acesso em: 28 abr. 2026.
APA
Chakraborty, S., Vishwas, S., Harish, V., Gupta, G., Paudel, K. R., Dhanasekaran, M., et al. (2024). Exploring nanoparticular platform in delivery of repurposed drug for Alzheimer’s disease: current approaches and future perspectives. Expert Opinion on Drug Delivery, 21, 1771-1792. doi:10.1080/17425247.2024.2414768
NLM
Chakraborty S, Vishwas S, Harish V, Gupta G, Paudel KR, Dhanasekaran M, Goh BH, Zacconi F, Pinto T de JA, Kumbhar P, Disouza J, Dual K, Singh SK. Exploring nanoparticular platform in delivery of repurposed drug for Alzheimer’s disease: current approaches and future perspectives [Internet]. Expert Opinion on Drug Delivery. 2024 ; 21 1771-1792.[citado 2026 abr. 28 ] Available from: https://dx.doi.org/10.1080/17425247.2024.2414768
Vancouver
Chakraborty S, Vishwas S, Harish V, Gupta G, Paudel KR, Dhanasekaran M, Goh BH, Zacconi F, Pinto T de JA, Kumbhar P, Disouza J, Dual K, Singh SK. Exploring nanoparticular platform in delivery of repurposed drug for Alzheimer’s disease: current approaches and future perspectives [Internet]. Expert Opinion on Drug Delivery. 2024 ; 21 1771-1792.[citado 2026 abr. 28 ] Available from: https://dx.doi.org/10.1080/17425247.2024.2414768
Artigo de periodico
Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation (2024)
Bashir, Bushra; Alam, Shahbaz; Khandale, Nikhil; Birla, Devendra; Vishwas, Sukriti ; Pandey, Narendra Kumar; Gupta, Gaurav; Paudel, Keshav Raj ; Dureja, Harish; Kumar, Puneet; Singh, Thakur Gurjeet; Kuppusamy, Gowthamarajan; Zacconi, Flavia C; Pinto, Terezinha de Jesus Andreoli ; Dhanasekaran, Muralikrishnan; Gulati, Monica; Dua, Kamal ; Singh, Sachin Kumar
Source: Ageing Research Reviews. Unidade: FCF
Subjects: DOENÇAS NEURODEGENERATIVAS, ENVELHECIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASHIR, Bushra et al. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews, v. 95, p. 1-16 art. 102236, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.arr.2024.102236. Acesso em: 28 abr. 2026.
APA
Bashir, B., Alam, S., Khandale, N., Birla, D., Vishwas, S., Pandey, N. K., et al. (2024). Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews, 95, 1-16 art. 102236. doi:10.1016/j.arr.2024.102236
NLM
Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P, Singh TG, Kuppusamy G, Zacconi FC, Pinto T de JA, Dhanasekaran M, Gulati M, Dua K, Singh SK. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation [Internet]. Ageing Research Reviews. 2024 ; 95 1-16 art. 102236.[citado 2026 abr. 28 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102236
Vancouver
Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P, Singh TG, Kuppusamy G, Zacconi FC, Pinto T de JA, Dhanasekaran M, Gulati M, Dua K, Singh SK. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation [Internet]. Ageing Research Reviews. 2024 ; 95 1-16 art. 102236.[citado 2026 abr. 28 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102236
Artigo de periodico
Unravelling the role of solid lipid nanoparticles in drug delivery: journey from laboratory to clinical trial (2023)
Harish, Vancha; Mohd, Sharfuddin ; Tewari, Devesh ; Pandey, Narendra Kumar; Vishwas, Sukriti ; Babu, Malakapogu Ravindra ; Salkini, Mohamad Ayman; Rehman, Zia ur; Alotaibi, Jehan Talaq; Alotaibi, Renad Fahad; Alrashed, Fahad Abdulaziz; Prasher, Parteek; Sharma, Nitin; Gupta, Gaurav; Jakhmola, Vikash; Singh, Yogendra; Pinto, Terezinha de Jesus Andreoli ; Paudel, Keshav Raj ; Mittal, Neeraj; Singh, Thakur Gurjeet; Arora, Poonam; Dua, Kamal; Singh, Sachin Kumar
Source: Journal of Drug Delivery Science and Technology. Unidade: FCF
Subjects: NANOPARTÍCULAS, ENSAIO CLÍNICO, BIODISPONIBILIDADE, SOLUBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HARISH, Vancha et al. Unravelling the role of solid lipid nanoparticles in drug delivery: journey from laboratory to clinical trial. Journal of Drug Delivery Science and Technology, v. 85, p. 1-19 art. 104616, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jddst.2023.104616. Acesso em: 28 abr. 2026.
APA
Harish, V., Mohd, S., Tewari, D., Pandey, N. K., Vishwas, S., Babu, M. R., et al. (2023). Unravelling the role of solid lipid nanoparticles in drug delivery: journey from laboratory to clinical trial. Journal of Drug Delivery Science and Technology, 85, 1-19 art. 104616. doi:10.1016/j.jddst.2023.104616
NLM
Harish V, Mohd S, Tewari D, Pandey NK, Vishwas S, Babu MR, Salkini MA, Rehman Z ur, Alotaibi JT, Alotaibi RF, Alrashed FA, Prasher P, Sharma N, Gupta G, Jakhmola V, Singh Y, Pinto T de JA, Paudel KR, Mittal N, Singh TG, Arora P, Dua K, Singh SK. Unravelling the role of solid lipid nanoparticles in drug delivery: journey from laboratory to clinical trial [Internet]. Journal of Drug Delivery Science and Technology. 2023 ; 85 1-19 art. 104616.[citado 2026 abr. 28 ] Available from: https://doi.org/10.1016/j.jddst.2023.104616
Vancouver
Harish V, Mohd S, Tewari D, Pandey NK, Vishwas S, Babu MR, Salkini MA, Rehman Z ur, Alotaibi JT, Alotaibi RF, Alrashed FA, Prasher P, Sharma N, Gupta G, Jakhmola V, Singh Y, Pinto T de JA, Paudel KR, Mittal N, Singh TG, Arora P, Dua K, Singh SK. Unravelling the role of solid lipid nanoparticles in drug delivery: journey from laboratory to clinical trial [Internet]. Journal of Drug Delivery Science and Technology. 2023 ; 85 1-19 art. 104616.[citado 2026 abr. 28 ] Available from: https://doi.org/10.1016/j.jddst.2023.104616
Artigo de periodico
Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling (2023)
Bhat, Asif Ahmad ; Gilhotra, Ritu; Singh, Yogendra; Sharma, Sanjay; Pinto, Terezinha de Jesus Andreoli ; Ferraz, Humberto Gomes ; Singh, Sachin Kumar ; Dua, Kamal ; Gupta, Gaurav
Source: Nanomedicine. Unidade: FCF
Subjects: DOENÇA PULMONAR OBSTRUTIVA CRÔNICA, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BHAT, Asif Ahmad et al. Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling. Nanomedicine, v. 18, n. 7, p. 583-587, 2023Tradução . . Disponível em: https://doi.org/10.2217/nnm-2023-0032. Acesso em: 28 abr. 2026.
APA
Bhat, A. A., Gilhotra, R., Singh, Y., Sharma, S., Pinto, T. de J. A., Ferraz, H. G., et al. (2023). Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling. Nanomedicine, 18( 7), 583-587. doi:10.2217/nnm-2023-0032
NLM
Bhat AA, Gilhotra R, Singh Y, Sharma S, Pinto T de JA, Ferraz HG, Singh SK, Dua K, Gupta G. Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling [Internet]. Nanomedicine. 2023 ; 18( 7): 583-587.[citado 2026 abr. 28 ] Available from: https://doi.org/10.2217/nnm-2023-0032
Vancouver
Bhat AA, Gilhotra R, Singh Y, Sharma S, Pinto T de JA, Ferraz HG, Singh SK, Dua K, Gupta G. Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling [Internet]. Nanomedicine. 2023 ; 18( 7): 583-587.[citado 2026 abr. 28 ] Available from: https://doi.org/10.2217/nnm-2023-0032
Artigo de periodico
Exploring the multifaceted potential of chlorogenic acid: journey from nutraceutical to nanomedicine (2023)
Singh, Sachin Kumar ; Thakur, Kiran ; Sharma, Vishal; Saini, Mamta ; Sharma, Diksha; Vishwas, Sukriti ; Kakoty, Violina ; Pal, Rashmi Saxena ; Chaitanya, M. V. N. L; Babu, Malakapogu Ravindra ; Gupta, Saurabh ; Rehman, Zia Ur; Smriti; Singla, Madhav ; Gupta, Gaurav ; Jakhmola, Vikash; Pinto, Terezinha de Jesus Andreoli ; Kumbhar, Popat; Disouza, John; Patravale, Vandana ; Dua, Kamal ; Gadewar, Manoj M
Source: South African Journal of Botany. Unidade: FCF
Subjects: CAFÉ, ANTIOXIDANTES, ANTI-INFLAMATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SINGH, Sachin Kumar et al. Exploring the multifaceted potential of chlorogenic acid: journey from nutraceutical to nanomedicine. South African Journal of Botany, v. 159, p. 658-677, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.sajb.2023.06.038. Acesso em: 28 abr. 2026.
APA
Singh, S. K., Thakur, K., Sharma, V., Saini, M., Sharma, D., Vishwas, S., et al. (2023). Exploring the multifaceted potential of chlorogenic acid: journey from nutraceutical to nanomedicine. South African Journal of Botany, 159, 658-677. doi:10.1016/j.sajb.2023.06.038
NLM
Singh SK, Thakur K, Sharma V, Saini M, Sharma D, Vishwas S, Kakoty V, Pal RS, Chaitanya MVNL, Babu MR, Gupta S, Rehman ZU, Smriti, Singla M, Gupta G, Jakhmola V, Pinto T de JA, Kumbhar P, Disouza J, Patravale V, Dua K, Gadewar MM. Exploring the multifaceted potential of chlorogenic acid: journey from nutraceutical to nanomedicine [Internet]. South African Journal of Botany. 2023 ; 159 658-677.[citado 2026 abr. 28 ] Available from: https://doi.org/10.1016/j.sajb.2023.06.038
Vancouver
Singh SK, Thakur K, Sharma V, Saini M, Sharma D, Vishwas S, Kakoty V, Pal RS, Chaitanya MVNL, Babu MR, Gupta S, Rehman ZU, Smriti, Singla M, Gupta G, Jakhmola V, Pinto T de JA, Kumbhar P, Disouza J, Patravale V, Dua K, Gadewar MM. Exploring the multifaceted potential of chlorogenic acid: journey from nutraceutical to nanomedicine [Internet]. South African Journal of Botany. 2023 ; 159 658-677.[citado 2026 abr. 28 ] Available from: https://doi.org/10.1016/j.sajb.2023.06.038
Artigo de periodico
Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems (2022)
Prasher, Parteek ; Sharma, Mousmee ; Singh, Sachin Kumar ; Gulati, Monica ; Jha, Niraj Kumar ; Gupta, Piyush Kumar ; Gupta, Gaurav ; Chellappan, Dinesh Kumar ; Zacconi, Flavia ; Pinto, Terezinha de Jesus Andreoli ; Chan, Yinghan ; Liu, Gang; Paudel, Keshav Raj ; Hansbro, Philip Michael ; Oliver, Brian Gregory George; Dua, Kamal
Source: Chemico Biological Interactions. Unidade: FCF
Subjects: DOENÇAS RESPIRATÓRIAS, MUCO, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRASHER, Parteek et al. Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems. Chemico Biological Interactions, v. 365, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.cbi.2022.110048. Acesso em: 28 abr. 2026.
APA
Prasher, P., Sharma, M., Singh, S. K., Gulati, M., Jha, N. K., Gupta, P. K., et al. (2022). Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems. Chemico Biological Interactions, 365, 1-14. doi:10.1016/j.cbi.2022.110048
NLM
Prasher P, Sharma M, Singh SK, Gulati M, Jha NK, Gupta PK, Gupta G, Chellappan DK, Zacconi F, Pinto T de JA, Chan Y, Liu G, Paudel KR, Hansbro PM, Oliver BGG, Dua K. Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems [Internet]. Chemico Biological Interactions. 2022 ; 365 1-14.[citado 2026 abr. 28 ] Available from: https://doi.org/10.1016/j.cbi.2022.110048
Vancouver
Prasher P, Sharma M, Singh SK, Gulati M, Jha NK, Gupta PK, Gupta G, Chellappan DK, Zacconi F, Pinto T de JA, Chan Y, Liu G, Paudel KR, Hansbro PM, Oliver BGG, Dua K. Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems [Internet]. Chemico Biological Interactions. 2022 ; 365 1-14.[citado 2026 abr. 28 ] Available from: https://doi.org/10.1016/j.cbi.2022.110048
Artigo de periodico
Reflection about the hemodialysis water microbiological quality in Brazil (2022)
Carvalho, Gabriela Corrêa ; Dua, Kamal ; Gupta, Gaurav ; Bugno, Adriana ; Pinto, Terezinha de Jesus Andreoli
Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: CONTROLE DA QUALIDADE, NEFROPATIAS, MICROBIOLOGIA DA ÁGUA, CONTAMINAÇÃO DA ÁGUA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Gabriela Corrêa et al. Reflection about the hemodialysis water microbiological quality in Brazil. Brazilian Journal of Pharmaceutical Sciences, v. 58, p. 1-13, 2022Tradução . . Disponível em: https://www.scielo.br/j/bjps/a/tg3KLKvmFyyYdmkZ9VxKN4P/?format=pdf&*lang=en. Acesso em: 28 abr. 2026.
APA
Carvalho, G. C., Dua, K., Gupta, G., Bugno, A., & Pinto, T. de J. A. (2022). Reflection about the hemodialysis water microbiological quality in Brazil. Brazilian Journal of Pharmaceutical Sciences, 58, 1-13. Recuperado de https://www.scielo.br/j/bjps/a/tg3KLKvmFyyYdmkZ9VxKN4P/?format=pdf&*lang=en
NLM
Carvalho GC, Dua K, Gupta G, Bugno A, Pinto T de JA. Reflection about the hemodialysis water microbiological quality in Brazil [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2022 ; 58 1-13.[citado 2026 abr. 28 ] Available from: https://www.scielo.br/j/bjps/a/tg3KLKvmFyyYdmkZ9VxKN4P/?format=pdf&*lang=en
Vancouver
Carvalho GC, Dua K, Gupta G, Bugno A, Pinto T de JA. Reflection about the hemodialysis water microbiological quality in Brazil [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2022 ; 58 1-13.[citado 2026 abr. 28 ] Available from: https://www.scielo.br/j/bjps/a/tg3KLKvmFyyYdmkZ9VxKN4P/?format=pdf&*lang=en
Artigo de periodico
Advanced drug delivery systems targeting NF-κB in respiratory diseases (2021)
Prasher, Parteek ; Sharma, Mousmee ; Chellappan, Dinesh Kumar ; Gupta, Gaurav ; Jha, Niraj Kumar; Singh, Sachin Kumar; MacLoughlin, Ronan ; Pinto, Terezinha de Jesus Andreoli ; Löbenberg, Raimar ; Dua, Kamal
Source: Future Medicinal Chemistry. Unidade: FCF
Subjects: DOENÇAS RESPIRATÓRIAS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRASHER, Parteek et al. Advanced drug delivery systems targeting NF-κB in respiratory diseases. Future Medicinal Chemistry, v. 13, n. 13, p. 1087-1090, 2021Tradução . . Disponível em: https://doi.org/10.4155/fmc-2021-0013. Acesso em: 28 abr. 2026.
APA
Prasher, P., Sharma, M., Chellappan, D. K., Gupta, G., Jha, N. K., Singh, S. K., et al. (2021). Advanced drug delivery systems targeting NF-κB in respiratory diseases. Future Medicinal Chemistry, 13( 13), 1087-1090. doi:10.4155/fmc-2021-0013
NLM
Prasher P, Sharma M, Chellappan DK, Gupta G, Jha NK, Singh SK, MacLoughlin R, Pinto T de JA, Löbenberg R, Dua K. Advanced drug delivery systems targeting NF-κB in respiratory diseases [Internet]. Future Medicinal Chemistry. 2021 ; 13( 13): 1087-1090.[citado 2026 abr. 28 ] Available from: https://doi.org/10.4155/fmc-2021-0013
Vancouver
Prasher P, Sharma M, Chellappan DK, Gupta G, Jha NK, Singh SK, MacLoughlin R, Pinto T de JA, Löbenberg R, Dua K. Advanced drug delivery systems targeting NF-κB in respiratory diseases [Internet]. Future Medicinal Chemistry. 2021 ; 13( 13): 1087-1090.[citado 2026 abr. 28 ] Available from: https://doi.org/10.4155/fmc-2021-0013
Artigo de periodico
Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases (2021)
Chan, Yinghan ; MacLoughlin, Ronan ; Tambuwala, Murtaza M ; Pabari, Ritesh M ; Singh, Sachin Kumar ; Pinto, Terezinha de Jesus Andreoli ; Gupta, Gaurav ; Chellappan, Dinesh Kumar ; Dua, Kamal
Source: Nanomedicine. Unidade: FCF
Subjects: DOENÇAS RESPIRATÓRIAS, NANOTECNOLOGIA, INFLAMAÇÃO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAN, Yinghan et al. Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases. Nanomedicine, v. 16, n. 16, p. 1351–1355, 2021Tradução . . Disponível em: https://doi.org/10.2217/nnm-2021-0087. Acesso em: 28 abr. 2026.
APA
Chan, Y., MacLoughlin, R., Tambuwala, M. M., Pabari, R. M., Singh, S. K., Pinto, T. de J. A., et al. (2021). Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases. Nanomedicine, 16( 16), 1351–1355. doi:10.2217/nnm-2021-0087
NLM
Chan Y, MacLoughlin R, Tambuwala MM, Pabari RM, Singh SK, Pinto T de JA, Gupta G, Chellappan DK, Dua K. Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases [Internet]. Nanomedicine. 2021 ; 16( 16): 1351–1355.[citado 2026 abr. 28 ] Available from: https://doi.org/10.2217/nnm-2021-0087
Vancouver
Chan Y, MacLoughlin R, Tambuwala MM, Pabari RM, Singh SK, Pinto T de JA, Gupta G, Chellappan DK, Dua K. Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases [Internet]. Nanomedicine. 2021 ; 16( 16): 1351–1355.[citado 2026 abr. 28 ] Available from: https://doi.org/10.2217/nnm-2021-0087
Parte de monografia/livro
Oxidative stress in neurology and in neurodegenerative processes (2020)
Gupta, Gaurav; Pathak, Sacchidanand; Rawat, Sarita; Mishra, Anurag; Singh, Yogendra; Mehta, Meenu; Satija, Saurabh; Khurana, Navneet; Pinto, Terezinha de Jesus Andreoli ; Shukla, Shakti; Pabreja, Kavita; Chellappan, Dinesh Kumar
Source: Role of oxidative stress in pathophysiology of diseases. Unidade: FCF
Subjects: ESTRESSE OXIDATIVO, NEUROLOGIA, DOENÇAS NEURODEGENERATIVAS, ESPÉCIES REATIVAS DE OXIGÊNIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUPTA, Gaurav et al. Oxidative stress in neurology and in neurodegenerative processes. Role of oxidative stress in pathophysiology of diseases. Tradução . Singapore: Springer Nature, 2020. . Disponível em: https://doi.org/10.1007/978-981-15-1568-2. Acesso em: 28 abr. 2026.
APA
Gupta, G., Pathak, S., Rawat, S., Mishra, A., Singh, Y., Mehta, M., et al. (2020). Oxidative stress in neurology and in neurodegenerative processes. In Role of oxidative stress in pathophysiology of diseases. Singapore: Springer Nature. doi:10.1007/978-981-15-1568-2
NLM
Gupta G, Pathak S, Rawat S, Mishra A, Singh Y, Mehta M, Satija S, Khurana N, Pinto T de JA, Shukla S, Pabreja K, Chellappan DK. Oxidative stress in neurology and in neurodegenerative processes [Internet]. In: Role of oxidative stress in pathophysiology of diseases. Singapore: Springer Nature; 2020. [citado 2026 abr. 28 ] Available from: https://doi.org/10.1007/978-981-15-1568-2
Vancouver
Gupta G, Pathak S, Rawat S, Mishra A, Singh Y, Mehta M, Satija S, Khurana N, Pinto T de JA, Shukla S, Pabreja K, Chellappan DK. Oxidative stress in neurology and in neurodegenerative processes [Internet]. In: Role of oxidative stress in pathophysiology of diseases. Singapore: Springer Nature; 2020. [citado 2026 abr. 28 ] Available from: https://doi.org/10.1007/978-981-15-1568-2
Artigo de periodico
Nanocarriers: more than tour de force for thymoquinone (2020)
Rathore, Charul; Rathbone, Michael J; Chellappan, Dinesh Kumar; Tambuwala, Murtaza M ; Pinto, Terezinha de Jesus Andreoli ; Dureja, Harish; Hemrajani, Chetna; Gupta, Gaurav ; Dua, Kamal; Negi, Poonam
Source: Expert Opinion on Drug Delivery. Unidade: FCF
Subjects: NANOPARTÍCULAS, BIODISPONIBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RATHORE, Charul et al. Nanocarriers: more than tour de force for thymoquinone. Expert Opinion on Drug Delivery, v. 17, n. 4, p. 479-494, 2020Tradução . . Disponível em: https://doi.org/10.1080/17425247.2020.1730808. Acesso em: 28 abr. 2026.
APA
Rathore, C., Rathbone, M. J., Chellappan, D. K., Tambuwala, M. M., Pinto, T. de J. A., Dureja, H., et al. (2020). Nanocarriers: more than tour de force for thymoquinone. Expert Opinion on Drug Delivery, 17( 4), 479-494. doi:10.1080/17425247.2020.1730808
NLM
Rathore C, Rathbone MJ, Chellappan DK, Tambuwala MM, Pinto T de JA, Dureja H, Hemrajani C, Gupta G, Dua K, Negi P. Nanocarriers: more than tour de force for thymoquinone [Internet]. Expert Opinion on Drug Delivery. 2020 ; 17( 4): 479-494.[citado 2026 abr. 28 ] Available from: https://doi.org/10.1080/17425247.2020.1730808
Vancouver
Rathore C, Rathbone MJ, Chellappan DK, Tambuwala MM, Pinto T de JA, Dureja H, Hemrajani C, Gupta G, Dua K, Negi P. Nanocarriers: more than tour de force for thymoquinone [Internet]. Expert Opinion on Drug Delivery. 2020 ; 17( 4): 479-494.[citado 2026 abr. 28 ] Available from: https://doi.org/10.1080/17425247.2020.1730808
Parte de monografia/livro
Pulmonary biodhesive drug delivery systems and their applications (2020)
Wadhwa, Ridhima; Chellappan, Dinesh Kumar; Maurya, Pawan Kumar; Pinto, Terezinha de Jesus Andreoli ; Collet, Trudi; Dureja, Harish; Hansbro, Philip M; Dua, Kamal; Bharathala, Subhashini; Aggarwal, Taru; Sehgal, Nikita; Kumar, Nitesh; Gupta, Gaurav
Source: Bioadhesives in drug delivery. Unidade: FCF
Subjects: FÁRMACOS (SISTEMA RESPIRATÓRIO), DOENÇAS RESPIRATÓRIAS, NANOPARTÍCULAS, BIODISPONIBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WADHWA, Ridhima et al. Pulmonary biodhesive drug delivery systems and their applications. Bioadhesives in drug delivery. Tradução . Hoboken: Wiley-Scrivener, 2020. . . Acesso em: 28 abr. 2026.
APA
Wadhwa, R., Chellappan, D. K., Maurya, P. K., Pinto, T. de J. A., Collet, T., Dureja, H., et al. (2020). Pulmonary biodhesive drug delivery systems and their applications. In Bioadhesives in drug delivery. Hoboken: Wiley-Scrivener.
NLM
Wadhwa R, Chellappan DK, Maurya PK, Pinto T de JA, Collet T, Dureja H, Hansbro PM, Dua K, Bharathala S, Aggarwal T, Sehgal N, Kumar N, Gupta G. Pulmonary biodhesive drug delivery systems and their applications. In: Bioadhesives in drug delivery. Hoboken: Wiley-Scrivener; 2020. [citado 2026 abr. 28 ]
Vancouver
Wadhwa R, Chellappan DK, Maurya PK, Pinto T de JA, Collet T, Dureja H, Hansbro PM, Dua K, Bharathala S, Aggarwal T, Sehgal N, Kumar N, Gupta G. Pulmonary biodhesive drug delivery systems and their applications. In: Bioadhesives in drug delivery. Hoboken: Wiley-Scrivener; 2020. [citado 2026 abr. 28 ]
Artigo de periodico
Hybrid molecules based on 1,3,5-triazine as potential therapeutics: a focused review (2020)
Prasher, Parteek ; Sharma, Mousmee; Aljabali, Alaa A. A; Gupta, Gaurav ; Negi, Poonam; Kapoor, Deepak N ; Singh, Inderbir; Zacconi, Flavia C; Pinto, Terezinha de Jesus Andreoli ; Silva, Mateus Webba da; Bakshi, Hamid A; Chellappan, Dinesh Kumar; Tambuwala, Murtaza M ; Dua, Kamal
Source: Drug Development Research. Unidade: FCF
Subjects: FÁRMACOS, COMPOSTOS ORGÂNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRASHER, Parteek et al. Hybrid molecules based on 1,3,5-triazine as potential therapeutics: a focused review. Drug Development Research, v. 81, p. 837–858, 2020Tradução . . Disponível em: https://doi.org/10.1002/ddr.21704. Acesso em: 28 abr. 2026.
APA
Prasher, P., Sharma, M., Aljabali, A. A. A., Gupta, G., Negi, P., Kapoor, D. N., et al. (2020). Hybrid molecules based on 1,3,5-triazine as potential therapeutics: a focused review. Drug Development Research, 81, 837–858. doi:10.1002/ddr.21704
NLM
Prasher P, Sharma M, Aljabali AAA, Gupta G, Negi P, Kapoor DN, Singh I, Zacconi FC, Pinto T de JA, Silva MW da, Bakshi HA, Chellappan DK, Tambuwala MM, Dua K. Hybrid molecules based on 1,3,5-triazine as potential therapeutics: a focused review [Internet]. Drug Development Research. 2020 ; 81 837–858.[citado 2026 abr. 28 ] Available from: https://doi.org/10.1002/ddr.21704
Vancouver
Prasher P, Sharma M, Aljabali AAA, Gupta G, Negi P, Kapoor DN, Singh I, Zacconi FC, Pinto T de JA, Silva MW da, Bakshi HA, Chellappan DK, Tambuwala MM, Dua K. Hybrid molecules based on 1,3,5-triazine as potential therapeutics: a focused review [Internet]. Drug Development Research. 2020 ; 81 837–858.[citado 2026 abr. 28 ] Available from: https://doi.org/10.1002/ddr.21704
Artigo de periodico
Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases (2019)
Mehta, Meenu; Deeksha; Sharma, Neha; Vyas, Manish; Khurana, Navneet; Maurya, Pawan Kumar; Singh, Harjeet; Pinto, Terezinha de Jesus Andreoli ; Dureja, Harish; Chellappan, Dinesh Kumar; Gupta, Gaurav; Wadhwa, Ridhima; Collet, Trudi; Hansbro, Philip M; Dua, Kamal; Satija, Saurabh
Source: Chemico Biological Interactions. Unidade: FCF
Subjects: ASMA, DOENÇAS RESPIRATÓRIAS, INFLAMAÇÃO, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEHTA, Meenu et al. Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases. Chemico Biological Interactions, v. 304, p. 10-19, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.cbi.2019.02.021. Acesso em: 28 abr. 2026.
APA
Mehta, M., Deeksha,, Sharma, N., Vyas, M., Khurana, N., Maurya, P. K., et al. (2019). Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases. Chemico Biological Interactions, 304, 10-19. doi:10.1016/j.cbi.2019.02.021
NLM
Mehta M, Deeksha, Sharma N, Vyas M, Khurana N, Maurya PK, Singh H, Pinto T de JA, Dureja H, Chellappan DK, Gupta G, Wadhwa R, Collet T, Hansbro PM, Dua K, Satija S. Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases [Internet]. Chemico Biological Interactions. 2019 ; 304 10-19.[citado 2026 abr. 28 ] Available from: https://doi.org/10.1016/j.cbi.2019.02.021
Vancouver
Mehta M, Deeksha, Sharma N, Vyas M, Khurana N, Maurya PK, Singh H, Pinto T de JA, Dureja H, Chellappan DK, Gupta G, Wadhwa R, Collet T, Hansbro PM, Dua K, Satija S. Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases [Internet]. Chemico Biological Interactions. 2019 ; 304 10-19.[citado 2026 abr. 28 ] Available from: https://doi.org/10.1016/j.cbi.2019.02.021
Artigo de periodico
Inflammasome gene expression is associated with immunopathology in human localized cutaneous leishmaniasis (2019)
Gupta, Gaurav; Santana, Alynne Karen Mendonça de; Gomes, Ciro Martins ; Turatti, Aline; Milanezi, Cristiane Maria; Bueno Filho, Roberto ; Fuzo, Carlos Alessandro ; Almeida, Roque Pacheco de ; Carregaro, Vanessa ; Roselino, Ana Maria Ferreira ; Silva, João Santana da
Source: Cellular Immunology. Unidades: FMRP, FCFRP
Subjects: LEISHMANIOSE CUTÂNEA, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUPTA, Gaurav et al. Inflammasome gene expression is associated with immunopathology in human localized cutaneous leishmaniasis. Cellular Immunology, v. 341, p. [8] , 2019Tradução . . Disponível em: https://doi.org/10.1016/j.cellimm.2019.04.008. Acesso em: 28 abr. 2026.
APA
Gupta, G., Santana, A. K. M. de, Gomes, C. M., Turatti, A., Milanezi, C. M., Bueno Filho, R., et al. (2019). Inflammasome gene expression is associated with immunopathology in human localized cutaneous leishmaniasis. Cellular Immunology, 341, [8] . doi:10.1016/j.cellimm.2019.04.008
NLM
Gupta G, Santana AKM de, Gomes CM, Turatti A, Milanezi CM, Bueno Filho R, Fuzo CA, Almeida RP de, Carregaro V, Roselino AMF, Silva JS da. Inflammasome gene expression is associated with immunopathology in human localized cutaneous leishmaniasis [Internet]. Cellular Immunology. 2019 ; 341 [8] .[citado 2026 abr. 28 ] Available from: https://doi.org/10.1016/j.cellimm.2019.04.008
Vancouver
Gupta G, Santana AKM de, Gomes CM, Turatti A, Milanezi CM, Bueno Filho R, Fuzo CA, Almeida RP de, Carregaro V, Roselino AMF, Silva JS da. Inflammasome gene expression is associated with immunopathology in human localized cutaneous leishmaniasis [Internet]. Cellular Immunology. 2019 ; 341 [8] .[citado 2026 abr. 28 ] Available from: https://doi.org/10.1016/j.cellimm.2019.04.008
Artigo de periodico
Tumor suppressor role of miR-503 (2018)
Gupta, Gaurav; Chellappan, Dinesh Kumar; Pinto, Terezinha de Jesus Andreoli ; Hansbro, Philip M; Bebawy, Mary; Dua, Kamal
Source: Panminerva Medica. Unidade: FCF
Subjects: ONCOGENES, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUPTA, Gaurav et al. Tumor suppressor role of miR-503. Panminerva Medica, v. 60, n. 1, p. 17-24, 2018Tradução . . Disponível em: https://doi.org/10.23736/S0031-0808.17.03386-9. Acesso em: 28 abr. 2026.
APA
Gupta, G., Chellappan, D. K., Pinto, T. de J. A., Hansbro, P. M., Bebawy, M., & Dua, K. (2018). Tumor suppressor role of miR-503. Panminerva Medica, 60( 1), 17-24. doi:10.23736/S0031-0808.17.03386-9
NLM
Gupta G, Chellappan DK, Pinto T de JA, Hansbro PM, Bebawy M, Dua K. Tumor suppressor role of miR-503 [Internet]. Panminerva Medica. 2018 ; 60( 1): 17-24.[citado 2026 abr. 28 ] Available from: https://doi.org/10.23736/S0031-0808.17.03386-9
Vancouver
Gupta G, Chellappan DK, Pinto T de JA, Hansbro PM, Bebawy M, Dua K. Tumor suppressor role of miR-503 [Internet]. Panminerva Medica. 2018 ; 60( 1): 17-24.[citado 2026 abr. 28 ] Available from: https://doi.org/10.23736/S0031-0808.17.03386-9
Artigo de periodico
A clinical update on metformin and lung cancer in diabetic patients (2018)
Gupta, Gaurav; Pinto, Terezinha de Jesus Andreoli ; Chellappa, Dinesh K; Mishra, Anurag; Malipe, Himaja; Dua, Kamal
Source: Panminerva Medica. Unidade: FCF
Subjects: DIABETES MELLITUS, METFORMINA, NEOPLASIAS PULMONARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUPTA, Gaurav et al. A clinical update on metformin and lung cancer in diabetic patients. Panminerva Medica, v. 60, n. 2, p. 70-75, 2018Tradução . . Disponível em: https://doi.org/10.23736/S0031-0808.18.03394-3. Acesso em: 28 abr. 2026.
APA
Gupta, G., Pinto, T. de J. A., Chellappa, D. K., Mishra, A., Malipe, H., & Dua, K. (2018). A clinical update on metformin and lung cancer in diabetic patients. Panminerva Medica, 60( 2), 70-75. doi:10.23736/S0031-0808.18.03394-3
NLM
Gupta G, Pinto T de JA, Chellappa DK, Mishra A, Malipe H, Dua K. A clinical update on metformin and lung cancer in diabetic patients [Internet]. Panminerva Medica. 2018 ; 60( 2): 70-75.[citado 2026 abr. 28 ] Available from: https://doi.org/10.23736/S0031-0808.18.03394-3
Vancouver
Gupta G, Pinto T de JA, Chellappa DK, Mishra A, Malipe H, Dua K. A clinical update on metformin and lung cancer in diabetic patients [Internet]. Panminerva Medica. 2018 ; 60( 2): 70-75.[citado 2026 abr. 28 ] Available from: https://doi.org/10.23736/S0031-0808.18.03394-3
Artigo de periodico
Embarking effect of ACE2-angiotensin 1-7/mas receptor axis in benign prostate hyperplasia (2018)
Singh, Yogendra; Gupta, Gaurav; Sharma, Rahul; Matta, Yogesh; Mishra, Anurag; Pinto, Terezinha de Jesus Andreoli ; Dua, Kamal
Source: Critical Reviews in Eukaryotic Gene Expression. Unidade: FCF
Subjects: DEFICIENTES, DOENÇAS GENÉTICAS, TRATAMENTO ODONTOLÓGICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SINGH, Yogendra et al. Embarking effect of ACE2-angiotensin 1-7/mas receptor axis in benign prostate hyperplasia. Critical Reviews in Eukaryotic Gene Expression, v. 28 , n. 2, p. 115-124, 2018Tradução . . Disponível em: https://doi.org/10.1615/CritRevEukaryotGeneExpr.2018021364. Acesso em: 28 abr. 2026.
APA
Singh, Y., Gupta, G., Sharma, R., Matta, Y., Mishra, A., Pinto, T. de J. A., & Dua, K. (2018). Embarking effect of ACE2-angiotensin 1-7/mas receptor axis in benign prostate hyperplasia. Critical Reviews in Eukaryotic Gene Expression, 28 ( 2), 115-124. doi:10.1615/CritRevEukaryotGeneExpr.2018021364
NLM
Singh Y, Gupta G, Sharma R, Matta Y, Mishra A, Pinto T de JA, Dua K. Embarking effect of ACE2-angiotensin 1-7/mas receptor axis in benign prostate hyperplasia [Internet]. Critical Reviews in Eukaryotic Gene Expression. 2018 ; 28 ( 2): 115-124.[citado 2026 abr. 28 ] Available from: https://doi.org/10.1615/CritRevEukaryotGeneExpr.2018021364
Vancouver
Singh Y, Gupta G, Sharma R, Matta Y, Mishra A, Pinto T de JA, Dua K. Embarking effect of ACE2-angiotensin 1-7/mas receptor axis in benign prostate hyperplasia [Internet]. Critical Reviews in Eukaryotic Gene Expression. 2018 ; 28 ( 2): 115-124.[citado 2026 abr. 28 ] Available from: https://doi.org/10.1615/CritRevEukaryotGeneExpr.2018021364
Artigo de periodico
Formulation, in-vitro and ex-vivo evaluation of tretinoin loaded cubosomal gel for the treatment of acne (2018)
Sureka, Shruti; Gupta, Gaurav; Agarwal, Mohit; Mishra, Anurag; Singh, Santosh K; Singh, Ravindra P; Sah, Sushil K; Pinto, Terezinha de Jesus Andreoli ; Dua, Kamal
Source: Recent Patents on Drug Delivery and Formulation. Unidade: FCF
Subjects: BIODEGRADAÇÃO, ACNE VULGAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SUREKA, Shruti et al. Formulation, in-vitro and ex-vivo evaluation of tretinoin loaded cubosomal gel for the treatment of acne. Recent Patents on Drug Delivery and Formulation, v. 12, n. 2, p. 121-129, 2018Tradução . . Disponível em: https://doi.org/10.2174/1872211312666180213121117. Acesso em: 28 abr. 2026.
APA
Sureka, S., Gupta, G., Agarwal, M., Mishra, A., Singh, S. K., Singh, R. P., et al. (2018). Formulation, in-vitro and ex-vivo evaluation of tretinoin loaded cubosomal gel for the treatment of acne. Recent Patents on Drug Delivery and Formulation, 12( 2), 121-129. doi:10.2174/1872211312666180213121117
NLM
Sureka S, Gupta G, Agarwal M, Mishra A, Singh SK, Singh RP, Sah SK, Pinto T de JA, Dua K. Formulation, in-vitro and ex-vivo evaluation of tretinoin loaded cubosomal gel for the treatment of acne [Internet]. Recent Patents on Drug Delivery and Formulation. 2018 ; 12( 2): 121-129.[citado 2026 abr. 28 ] Available from: https://doi.org/10.2174/1872211312666180213121117
Vancouver
Sureka S, Gupta G, Agarwal M, Mishra A, Singh SK, Singh RP, Sah SK, Pinto T de JA, Dua K. Formulation, in-vitro and ex-vivo evaluation of tretinoin loaded cubosomal gel for the treatment of acne [Internet]. Recent Patents on Drug Delivery and Formulation. 2018 ; 12( 2): 121-129.[citado 2026 abr. 28 ] Available from: https://doi.org/10.2174/1872211312666180213121117
Trabalho de evento-resumo
Idarubicin loaded nanoparticles for breast cancer (2018)
Braga, Marina de Souza; Carvalho, Gabriela Corrêa; Dua, Kamal; Gupta, Gaurav; Oliveira, Adriano; Cerize, Natalia Neto Pereira; Pinto, Terezinha de Jesus Andreoli
Source: Abstracts. Conference titles: World Congress on Recent Advances in Nanotechnology. Unidade: FCF
Subjects: NANOPARTÍCULAS, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAGA, Marina de Souza et al. Idarubicin loaded nanoparticles for breast cancer. 2018, Anais.. Ontário: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, 2018. Disponível em: https://doi.org/10.11159/nddte18.119. Acesso em: 28 abr. 2026.
APA
Braga, M. de S., Carvalho, G. C., Dua, K., Gupta, G., Oliveira, A., Cerize, N. N. P., & Pinto, T. de J. A. (2018). Idarubicin loaded nanoparticles for breast cancer. In Abstracts. Ontário: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.11159/nddte18.119
NLM
Braga M de S, Carvalho GC, Dua K, Gupta G, Oliveira A, Cerize NNP, Pinto T de JA. Idarubicin loaded nanoparticles for breast cancer [Internet]. Abstracts. 2018 ;[citado 2026 abr. 28 ] Available from: https://doi.org/10.11159/nddte18.119
Vancouver
Braga M de S, Carvalho GC, Dua K, Gupta G, Oliveira A, Cerize NNP, Pinto T de JA. Idarubicin loaded nanoparticles for breast cancer [Internet]. Abstracts. 2018 ;[citado 2026 abr. 28 ] Available from: https://doi.org/10.11159/nddte18.119

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration